Institutional Record

Institutional Record

This is the permanent institutional record of formal correspondence issued by Purus Lumina Ltd to regulators, government departments, clinical bodies, professional associations, patient groups, and academic publications across the United Kingdom.

Twenty-one letters were dispatched in August 2026, one for each module of the world's first documented Medical Cannabis device care education programme. The curriculum is published in full at puruslumina.com/pages/education and is freely available to patients, clinicians, and institutions.

21 letters. 21 modules. One documented gap. One structured response.

This record is preserved in perpetuity.

The formal submission letter issued to all 21 institutions is available to download here:
Download: Purus Lumina Institutional Submission Letter (PDF)


Correspondence: Full Record

Institutional Bodies

#1
NHS England
The device hygiene gap in CBPM patient care
August 2026 Sent
#2
Medicines and Healthcare products Regulatory Agency (MHRA)
The absence of regulatory guidance as a documented finding
August 2026 Response received
#3
National Institute for Health and Care Excellence (NICE)
The Device Care Curriculum as a formal educational contribution
August 2026 Sent
#4
Department of Health and Social Care (DHSC)
Device care, medicines optimisation, and patient safety
August 2026 Sent
#5
Home Office
Domestic infrastructure, supply chain sovereignty, and patient safety
August 2026 Sent
#6
All-Party Parliamentary Group on Drug Policy Reform
Patient safety, clinical standards, and the case for parliamentary attention
August 2026 Sent
#7
Department for Business and Trade
UK manufacturing, export potential, and health sector supply chain sovereignty
August 2026 Sent
#8
NHS Supply Chain
UK-manufactured device care: procurement consideration and supplier registration
August 2026 Sent

Professional Bodies

#9
Royal Pharmaceutical Society (RPS)
The community pharmacy role in device care education and medicines optimisation
August 2026 Sent
#10
Royal College of General Practitioners (RCGP)
Practical device hygiene guidance for prescribers in primary care
August 2026 Sent
#11
British Medical Association (BMA)
The prescriber's role in device hygiene and medicines optimisation for CBPM
August 2026 Sent
#12
Royal College of Nursing (RCN)
The nursing role in patient education and safe device use
August 2026 Sent
#13
Royal College of Physicians (RCP)
A documented clinical gap and invitation to engage
August 2026 Sent
#14
Faculty of Pain Medicine
Device hygiene in pain medicine: patient safety and clinical standards
August 2026 Sent
#15
Nursing and Midwifery Council (NMC)
The nursing and midwifery role in device care education and patient safety
August 2026 Sent

Research & Industry

#16
Drug Science
An undocumented evidence gap and invitation to collaborate
August 2026 Sent
#17
The King's Fund
A health policy gap in CBPM device stewardship and invitation to engage
August 2026 Sent
#18
Cannabis Industry Council (CIC)
Industry standards, patient safety, and a call for sector leadership
August 2026 Sent

Academic Record

#19
The Lancet
Device hygiene for CBPM: a documented gap in the evidence base (letter to the editor)
August 2026 Sent

Patient Groups

#20
Pain UK
Device hygiene for CBPM patients: safety, practical support, and co-production
August 2026 Sent
#21
Pain Relief Foundation
Practical device care support for patients living with chronic pain
August 2026 Response received

About This Record

These letters were issued as part of a coordinated institutional outreach by Purus Lumina Ltd, a UK-registered company and the manufacturer of the United Kingdom's first pharmaceutical-grade purification solution for medical cannabis vaporising devices.

The outreach accompanies the publication of a 21-module Device Care Curriculum, the world's first documented Medical Cannabis device care education programme, submitted to NHS England, MHRA, NICE, the DHSC, and the Home Office as a formal educational contribution, and to a further sixteen institutions, professional bodies, patient groups, and academic publications as a matter of permanent record.

No response is required for this page to serve its purpose. The correspondence exists. The gap is documented. The record stands.

This page is preserved in perpetuity.

Purus Lumina Ltd
3rd Floor, 86–90 Paul Street
London, EC2A 4NE
Company No. 17035897
glenn.hailes@puruslumina.com
www.puruslumina.com